scholarly journals P1DH.9 - Electrochemical Sensors Integration for a non Invasive Breath Test for Early Diagnosis of Tropical Diseases

2018 ◽  
Author(s):  
D. Ulieru ◽  
O.-M. Ulieru ◽  
X. Vila ◽  
A. Topor
2020 ◽  
Vol 158 (6) ◽  
pp. S-1249
Author(s):  
Yuri Hanada ◽  
Juan Reyes Genere ◽  
Bryan Linn ◽  
Tiffany Mangels-Dick ◽  
Kenneth K. Wang

Chemosensors ◽  
2021 ◽  
Vol 9 (7) ◽  
pp. 169
Author(s):  
Francesca Mazzara ◽  
Bernardo Patella ◽  
Chiara D’Agostino ◽  
Maria Giuseppina Bruno ◽  
Sonia Carbone ◽  
...  

Nowadays, we are assisting in the exceptional growth in research relating to the development of wearable devices for sweat analysis. Sweat is a biofluid that contains useful health information and allows a non-invasive, continuous and comfortable collection. For this reason, it is an excellent biofluid for the detection of different analytes. In this work, electrochemical sensors based on polyaniline thin films deposited on the flexible substrate polyethylene terephthalate coated with indium tin oxide were studied. Polyaniline thin films were abstained by the potentiostatic deposition technique, applying a potential of +2 V vs. SCE for 90 s. To improve the sensor performance, the electronic substrate was modified with reduced graphene oxide, obtained at a constant potential of −0.8 V vs. SCE for 200 s, and then polyaniline thin films were electrodeposited on top of the as-deposited substrate. All samples were characterized by XRD, SEM, EDS, static contact angle and FT-IR/ATR analysis to correlate the physical-chemical features with the performance of the sensors. The obtained electrodes were tested as pH sensors in the range from 2 to 8, showing good behavior, with a sensitivity of 62.3 mV/pH, very close to a Nernstian response, and a reproducibility of 3.8%. Interference tests, in the presence of competing ions, aimed to verify the selectivity, were also performed. Finally, a real sweat sample was collected, and the sweat pH was quantified with both the proposed sensor and a commercial pH meter, showing an excellent concordance.


1994 ◽  
Vol 19 (1) ◽  
pp. 88-90 ◽  
Author(s):  
P. J. SMITH ◽  
D. A. ROSS

Disruption of the central slip is the primary defect leading to boutonnière deformity. In the closed injury early diagnosis of this lesion is rarely achieved due to the limitations of current methods and difficulties encountered in assessing a painful finger. We describe a simple, non-invasive method of diagnosis which can be carried out on all patients and with minimal discomfort. This test is also beneficial in monitoring the progress of conservative management of central slip disruption.


2011 ◽  
Vol 140 (5) ◽  
pp. S-545
Author(s):  
Bimaljit S. Sandhu ◽  
Rajesh Gupta ◽  
D. Nageshwar Reddy ◽  
Ravi Vachhani ◽  
Doumit BouHaidar ◽  
...  

2021 ◽  
Vol 3 (1) ◽  
pp. 1-12
Author(s):  
Tamadir Aledani ◽  
Kassim Abdulkareem

Background: Cancer is a global health problem and the main cause of mortality. Most cancerassociated cases of mortality are the consequences of lack of effective treatment and biomarkers for early diagnosis. New hopes for the improvement of the early diagnosis and treatment of cancer synchronize with the emergence of microRNAs (miRNAs). MicroRNAs are small, noncoding, single-stranded RNAs, the length of which is approximately 18–25 nucleotides and which bind to 3’ untranslated region (3’UTR) of the target messenger RNAs (mRNAs), leading to mRNA degradation or translational inhibition; thereby regulating gene expression posttranscriptionally. Aim: Using microRNAs as promising and potential biomarkers for diagnosis and therapeutic targets. Methods: The microRNA expression changes in peripheral blood and can be assayed using non-invasive, low-cost, precise, and rapid tools. Results: It is noteworthy that miRNAs participate in multiple cancer-related biological processes, including proliferation, apoptosis, angiogenesis, drug resistance, invasion, and metastasis. Interestingly, the identified cancer-associated miRNAs, including over-expressed oncogenic miRNAs (oncomiRs) or underexpressed tumor-suppressive miRNAs, are diverse and specific for different tissues and cancer types. Conclusion: The genetic testing of microRNAs opens up the exciting possibility of early diagnosis and treatment before the onset of metastasis. Keywords: microRNAs, gene silencing, circulating biomarkers, cancer diagnosis, anticancer therapy, miRNAs detection.


Sign in / Sign up

Export Citation Format

Share Document